Inventor
Zelda Wasserman
Inventor
Wilmington, DE, US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds40%
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
Y02ATechnologies for adaptation to climate change15%
PatentTitleYear
7,482,372'Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)'20096,906,053'Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)'20056,890,915'Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)'20056,610,731'Lactam metalloprotease inhibitors'20036,403,632'Lactam metalloprotease inhibitors'20026,342,503'1N-alkyl-n-arylpyrimidinamines and derivatives thereof'20026,107,301'1N-alkyl-N-arylpyrimidinamines and derivatives thereof'20006,057,336'Lactam metalloprotease inhibitors'2000Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2000–2002Patents assigned to DU PONT PHARM CO (2)· patent assignee history
2000Patents assigned to DU PONT (1)· patent assignee history
2000–2009Based in Wilmington, DE, US· patent location history
2002–2005Patents assigned to BRISTOL MYERS SQUIBB PHARMA CO (3)· patent assignee history
2003–2009Patents assigned to BRISTOL MYERS SQUIBB CO (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB PHARMA CO | 3 | 2002–2005 |
| BRISTOL MYERS SQUIBB CO | 2 | 2003–2009 |
| DU PONT PHARM CO | 2 | 2000–2002 |
| DU PONT | 1 | 2000 |
Locations
| Location | Patents | Span |
|---|---|---|
| Wilmington, Delaware, US | 8 | 2000–2009 |